Australian biotech market today 03.04.09
Friday, 03 April, 2009
A very flat day’s trading on the ASX saw biotech and pharma go against the grain at the close of trade today, with a slight drop in indices as opposed to overall gains.
Starpharma (ASX:SPL) has called a trading halt until an announcement on Tuesday.
Atcor (ASX:ACG) is down 1c, which still means a 7 per cent drop in value, while Acrux (ASX:ACR) is up 3c, or 5.6 per cent.
Bionomics (ASX:BNO) is down a touch, as is Biota (ASX:BTA).
Circadian Technologies (ASX:CIR) is up 3c, as is CathRx (ASX:CXD), while Clinuvel (ASX:CUV) is up two.
With the Big Three, Cochlear (ASX:COH) has dropped below $50 while CSL (ASX:CSL) is down $1 on high volumes. ResMed (ASX:RMD) is down a touch, too.
Mesoblast (ASX:MSB) is down on a change in substantial shareholding and Pharmaxis (ASX:PXS) is still riding the wave of recent good interim data, up to $1.88.
Inhaled form of blood thinner treats serious COVID infections
Heparin has traditionally been injected and used to treat blood clots, but the new study tested...
Next-gen therapies could treat high-grade gliomas
Government funding will enable researchers to test a suite of next-generation therapies they have...
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
